MedTrace Logo

Neurophenotype Predicts CD Disease Progression

NCT06452550 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-06-11

No results posted yet for this study

Summary

The goal of this observational study is aimed to develop a novel multimodal neuroimaging-based model to characterize the neurophenotype of Crohn's Disease patients and assess its ability for predicting disease progression, using multiomics data to interpret the model.

Participants will be followed-up of at least six months for patients without disease progression to assess the relationship between neurophenotype and intestinal outcomes.

Conditions

  • Radiomics
  • Multi-omics

Interventions

DIAGNOSTIC_TEST

Logistic regression (LR) prediction models

Logistic regression model was used to establish a model to distinguish different levels of intestinal inflammation.

Sponsors & Collaborators

  • First Affiliated Hospital, Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Xuehua Li · Sun Yat-sen University First Affiliated Hospital Department of Radiology

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2025-06-01
Completion
2025-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06452550 on ClinicalTrials.gov